Vanguard Asset Management »

Theravance Biopharma shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $416k 26k 16.23